secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neumora Therapeutics, Inc. (NMRA)
CIK:        0001885522
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001193125-24-003968
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neumora makes corporate presentation available at J.P. Morgan Healthcare Conference
--------------------------------------------------------------------------------

- Presentation furnished as Exhibit 99.1; no financial or pipeline specifics provided in the filing text.
- Company plans to use presentation for investor and analyst meetings at 42nd Annual J.P. Morgan Healthcare Conference.
- No new material disclosures beyond availability of the presentation were included in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1885522/000119312524003968/0001193125-24-003968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1885522/000119312524003968/d104627d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-003968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer